Research Analysts Offer Predictions for VRTX Q2 Earnings
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at William Blair issued their Q2 2025 earnings per share estimates for shares of Vertex Pharmaceuticals in a report released on Tuesday, May 6th. William Blair analyst M. Minter forecasts that the pharmaceutical company will earn $3.95 per share for the quarter. William Blair […]
